Kliniken der Stadt Köln gGmbH

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Acute myeloid leukaemia1 trial
• Bladder cancer1 trial
• Childhood cancers1 trial
• Colorectal cancer1 trial
• Down syndrome1 trial
• Endometrial cancer1 trial
• Gastric and oesophageal cancer1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Metastatic breast cancer1 trial
• Ovarian cancer1 trial
• and 2 more

Phase

• Phase 33 trials
• Phase 41 trial

Status

• Suspended2 trials
• Active, not recruiting1 trial
• Completed1 trial
• Not yet recruiting1 trial

Lead sponsor

• GPOH gGmbH2 trials
• ImmunityBio, Inc.1 trial
• Institut Für Frauengesundheit GmbH1 trial
• Lindis Bloodcare GmbH1 trial

Running trials

• Recruiting

  Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

  NCT06745908· Phase 3· ImmunityBio, Inc.· Source

• Active, not recruiting

  CAPTOR-BC: COMPREHENSIVE ANALYSIS OF SPATIAL, TEMPORAL AND MOLECULAR PATTERNS OF RIBOCICLIB EFFICACY AND RESISTANCE IN ADVANCED BREAST CANCER PATIENTS

  NCT05452213· Phase 4· Institut Für Frauengesundheit GmbH· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting

Closed trials

• Completed

  Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device

  NCT06789224· Lindis Bloodcare GmbH· Source